erythromycin has been researched along with cefuroxime in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (12.12) | 18.7374 |
| 1990's | 23 (34.85) | 18.2507 |
| 2000's | 23 (34.85) | 29.6817 |
| 2010's | 11 (16.67) | 24.3611 |
| 2020's | 1 (1.52) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, SD; Singh, KP; Voolmann, T | 1 |
| Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
| Kronvall, G; Ringertz, S; Rylander, M | 1 |
| Ducroix, JP; Gaudio, F; Laurans, G; Orfila, J | 1 |
| Gleckman, RA | 1 |
| Andrew, M; Brandtzaeg, P; Gaustad, P; Halstensen, A; Hjortdahl, P; Høiby, EA | 1 |
| Bergeron, MG; L'Ecuyer, J; Provencher, P; Tremblay, LD | 1 |
| Easmon, CS; Gedney, J; Ison, CA | 1 |
| Ison, CA; Woodford, N | 1 |
| Finch, R; Martin, J; Pilkington, R | 1 |
| Gezelius, L; Liljequist, BO | 1 |
| Frimodt-Møller, N; Thomsen, VF | 1 |
| Ansink-Schipper, MC; Dessens-Kroon, M; Huikeshoven, H; van Klingeren, B; Woudstra, R | 1 |
| Forsgren, A; Walder, M | 1 |
| Brorson, JE; Zackrisson, G | 1 |
| Asikainen, S; Forsblom, B; Jousimies-Somer, H; Pajukanta, R; Piekkola, M | 1 |
| Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
| Afghani, B; Stutman, HR | 1 |
| Meyer, DR; Steele, RJ | 1 |
| Box, SA; Lee, MR | 1 |
| Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A | 1 |
| Lanbeck, P; Paulsen, O | 2 |
| Baños, V; Canteras, M; Gómez, J; Muñoz, L; Nuñez, ML; Ruiz Gómez, J; Soto, MC; Valdés, M | 1 |
| Bermejo, M; García-de-Lomas, J; García-Ponte, L; Garijo, B; Gimeno, C; Lázaro, MA; Millás, E; Navarro, D | 1 |
| Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
| Eliopoulos, GM; Souli, M; Wennersten, CB | 1 |
| Barg, N | 1 |
| Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
| Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C | 1 |
| Friedman, HS; Mishra, A; Sinha, AK | 1 |
| Callister, SM; Jobe, DA; Rawal, N; Schell, RF | 1 |
| Rose, GE; Vardy, SJ | 1 |
| Bates, J; File, TM; Grayston, JT; Indorf, A; Phillips, J; Sarosi, GA; Summersgill, J; Tan, J; Vergis, EN; YU, VL | 1 |
| See, S | 1 |
| Rollins, G | 1 |
| Forrest, A; Gudgel, LD; Niederman, MS; Paladino, JA | 1 |
| Danziger, LH; Neuhauser, MM; Pendland, SL; Prause, JL | 1 |
| Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
| Allan, RC; Melzer, M; Moghal, M; Wijesuriya, V | 1 |
| Byrne, AM; McCarthy, T; Morris, S; O'byrne, JM; Quinlan, W | 1 |
| Cars, O; Karlsson, MO; Löwdin, E; Nielsen, EI; Sandström, M; Viberg, A | 1 |
| Benninger, MS; Brown, NP; Evangelista, AT; Sahm, DF; Thornsberry, C; Yee, YC | 1 |
| Cars, O; Friberg, LE; Nielsen, EI | 2 |
| Abriouel, H; Fernández Fuentes, MA; Gadea, R; Gálvez, A; Ortega, E; Pérez Pulido, R | 1 |
| Iatrou, EI; Stasinakis, AS; Thomaidis, NS | 1 |
| Biscaro, V; Caruso, A; De Francesco, MA; Gargiulo, F; Piccinelli, G | 1 |
| Gomes, T; Huang, A; Juurlink, DN; Macdonald, EM; Mamdani, MM; Quinn, KL | 1 |
| Chokephaibulkit, K; Gamil, A; Phongsamart, W; Piralam, B; Techasaensiri, C; Thamaree, R | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Arpin, C; Fournier, M; Gagné, S; Hernould, M; Quentin, C | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
| Aguilar, L; Biek, D; Fenoll, A; Giménez, MJ; Granizo, JJ; Robledo, O; Tarragó, D | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Baljer, G; Hanssen-Hübner, C; Hunfeld, KP; Kraiczy, P; Morgenstern, K; Norris, DE | 1 |
| Caugant, DA; Fredlund, H; Hedberg, ST; Nicolas, P; Olcén, P; Unemo, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for erythromycin and cefuroxime
| Article | Year |
|---|---|
Pneumococcal disease in Thailand.
Topics: Anti-Bacterial Agents; Cefuroxime; Cost of Illness; Cost-Benefit Analysis; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Immunization Programs; Nasopharynx; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Prevalence; Serogroup; Streptococcus pneumoniae; Thailand | 2021 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for erythromycin and cefuroxime
| Article | Year |
|---|---|
Prevention of cellulitis after open lacrimal surgery: a prospective study of three methods.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Cellulitis; Cephalexin; Cephalosporins; Dacryocystorhinostomy; Erythromycin; Female; Humans; Intraoperative Care; Male; Middle Aged; Postoperative Care; Prospective Studies; Therapeutic Irrigation | 2000 |
Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia; Prospective Studies | 2000 |
Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Cefuroxime; Community-Acquired Infections; Confidence Intervals; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Erythromycin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia; Probability; Sensitivity and Specificity | 2002 |
Outcome following deep wound contamination in cemented arthroplasty.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Cefuroxime; Cementation; Disinfection; Erythromycin; Humans; Infection Control; Infections; Joint Prosthesis; Prospective Studies; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Treatment Outcome | 2007 |
60 other study(ies) available for erythromycin and cefuroxime
| Article | Year |
|---|---|
Pneumococcal bacteraemia in south Auckland: a five year review with emphasis on prescribing practices.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Child; Child, Preschool; Clavulanic Acids; Drug Combinations; Drug Prescriptions; Erythromycin; Female; Humans; Incidence; Infant; Male; Meningitis, Pneumococcal; New Zealand; Penicillin G; Pneumococcal Infections; Pneumonia, Pneumococcal; Practice Patterns, Physicians'; Retrospective Studies; Streptococcus pneumoniae | 1992 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae.
Topics: Ampicillin; Cefuroxime; Ciprofloxacin; Culture Media; Doxycycline; Drug Resistance, Microbial; Erythromycin; Hemoglobins; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Regression Analysis; Reproducibility of Results; Spectinomycin; Tetracycline | 1991 |
[In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefuroxime; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; In Vitro Techniques; Moraxella catarrhalis | 1991 |
Pneumonia: update on diagnosis and treatment.
Topics: Aged; Anti-Bacterial Agents; Cefuroxime; Erythromycin; Hospitalization; Humans; Pneumonia; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
[Treatment of infections caused by group A beta-hemolytic streptococci].
Topics: Adult; Cefuroxime; Child; Clindamycin; Erythromycin; Humans; Hygiene; Penicillin G; Penicillin V; Streptococcal Infections; Streptococcus pyogenes | 1990 |
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Canada; Cefaclor; Cefamandole; Cefazolin; Cefotaxime; Cefuroxime; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Haemophilus influenzae; Rifampin; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Chromosomal resistance of gonococci to antibiotics.
Topics: Anti-Bacterial Agents; Cefuroxime; Drug Resistance, Microbial; Erythromycin; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Serotyping; Tetracycline; Tetracycline Resistance | 1987 |
The effect of media on antimicrobial susceptibility testing of Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cefuroxime; Culture Media; Erythromycin; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Tetracycline | 1988 |
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Topics: Amoxicillin; Ampicillin; beta-Lactamases; Cefaclor; Cefuroxime; Cephaloridine; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseriaceae; Penicillin G | 1986 |
The pneumococcus and the mouse-protection test: correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamicin.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Dose-Response Relationship, Drug; Erythromycin; Gentamicins; In Vitro Techniques; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Vancomycin | 1987 |
Relation between nutritional requirements and susceptibilities to antibiotics of strains of Neisseria gonorrhoeae from pharyngeal and anogenital sites.
Topics: Aminopeptidases; Anal Canal; Anti-Bacterial Agents; Cefuroxime; Erythromycin; Genitalia; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Pharynx; Tetracyclines; Thiamphenicol | 1985 |
Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Dose-Response Relationship, Drug; Doxycycline; Drug Combinations; Erythromycin; Haemophilus influenzae; Humans; Neisseria; Penicillin Resistance; Penicillin V; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Antibiotic sensitivity pattern of recent clinical isolates of Streptococcus pneumoniae.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Chloramphenicol; Clindamycin; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim | 1981 |
Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Doxycycline; Erythromycin; Evaluation Studies as Topic; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Porphyromonas gingivalis; Tetracyclines | 1994 |
In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Metronidazole; Penicillin G; Penicillin Resistance; Serotyping; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Bacterial arthritis caused by Corynebacterium diphtheriae.
Topics: Adult; Arthritis, Infectious; Biopsy; Cefuroxime; Child, Preschool; Corynebacterium diphtheriae; Diphtheria; Diphtheria Toxoid; Drainage; Erythromycin; Female; Hip; Humans; Infusions, Intravenous; Penicillins | 1993 |
Nasolacrimal duct obstruction and acute dacryocystitis associated with infectious mononucleosis (Epstein-Barr virus)
Topics: Cefuroxime; Cephalosporins; Child; Dacryocystitis; Drug Therapy, Combination; Erythromycin; Eye Infections, Bacterial; Herpesvirus 4, Human; Humans; Immunoglobulin G; Immunoglobulin M; Infectious Mononucleosis; Lacrimal Duct Obstruction; Male; Staphylococcal Infections; Staphylococcus | 1993 |
A systemic reaction following exposure to a pyrethroid insecticide.
Topics: Abdominal Pain; Agricultural Workers' Diseases; Analgesics, Opioid; Animals; Anti-Allergic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Cefuroxime; Cephalosporins; Chlorpheniramine; Erythromycin; Humans; Ibuprofen; Insecticides; Male; Meperidine; Middle Aged; Occupational Exposure; Pruritus; Pyrethrins; Sheep; Urticaria; Vomiting | 1996 |
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1996 |
Cytotoxic effects of four antibiotics on endothelial cells.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cattle; Cefuroxime; Cell Survival; Cells, Cultured; Cephalosporins; Dicloxacillin; DNA; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Erythromycin; Humans; Infant, Newborn; Penicillin G; Penicillins; Platelet Aggregation Inhibitors; Proteins; Serotonin Antagonists | 1995 |
Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Chlamydophila pneumoniae; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus influenzae; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Penicillin Resistance; Pneumonia, Bacterial; Prognosis; Prospective Studies; Streptococcus pneumoniae | 1996 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Carrier State; Cefaclor; Cefuroxime; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Infant; Microbial Sensitivity Tests; Penicillins; Spain; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens.
Topics: Amoxicillin; Anti-Infective Agents; Aza Compounds; Cefuroxime; Clavulanic Acid; Erythromycin; Fluoroquinolones; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Penicillin Resistance; Quinolines; Quinolones; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes | 1998 |
Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Clarithromycin; Disease Models, Animal; Erythromycin; Fasciitis, Necrotizing; Mice; Mice, Hairless; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes | 1998 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
[Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996].
Topics: Acute Disease; Amoxicillin; beta-Lactam Resistance; beta-Lactams; Cefpodoxime; Ceftizoxime; Cefuroxime; Erythromycin; France; Humans; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Penicillins; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
The effects of erythromycin on the electrocardiogram.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Electrocardiography; Erythromycin; Female; Heart Rate; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1999 |
Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Blotting, Western; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Doxycycline; Erythromycin; False Positive Reactions; Humans; Immunoglobulin G; Immunoglobulin M; In Vitro Techniques; Lyme Disease; Penicillins | 1999 |
Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Hospitalization; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic | 2000 |
Short-term effects of four antibiotics on DNA synthesis in endothelial cells.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefuroxime; Cells, Cultured; Dicloxacillin; DNA; Dose-Response Relationship, Drug; Endothelium, Vascular; Erythromycin; Humans; Nucleic Acid Synthesis Inhibitors; Penicillin G; Thymidine; Time Factors; Umbilical Veins | 2001 |
Single antibiotic therapy as effective as dual in treating patients hospitalized with community acquired pneumonia.
Topics: Azithromycin; Cefuroxime; Cost Savings; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Outcome and Process Assessment, Health Care; Pneumonia; Practice Guidelines as Topic; Treatment Outcome; United States | 2000 |
In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Culture Media; Drug Therapy, Combination; Erythromycin; Humans; Ketolides; Kinetics; Methyltransferases; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
[Susceptibility of Branhamella catarrhalis to antibiotics].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefotaxime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Erythromycin; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 2004 |
University-acquired pneumonia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Community-Acquired Infections; Erythromycin; Humans; Male; Meningococcal Infections; Neisseria meningitidis; Pneumonia, Bacterial; Students | 2006 |
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.
Topics: Algorithms; Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Dose-Response Relationship, Drug; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin | 2007 |
Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001-2005).
Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Cefuroxime; Cephalosporin Resistance; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Paranasal Sinuses; Penicillin Resistance; Population Surveillance; Streptococcus pneumoniae; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2007 |
Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic-pharmacodynamic model.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin | 2011 |
Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Cefuroxime; Computer Simulation; Erythromycin; Escherichia coli; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G; Quinolines; Streptococcus pyogenes; Vancomycin | 2011 |
Synergistic activity of biocides and antibiotics on resistant bacteria from organically produced foods.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Chryseobacterium; Ciprofloxacin; Disinfectants; Drug Resistance, Bacterial; Drug Synergism; Enterobacter; Enterococcus; Erythromycin; Food, Organic; Klebsiella; Lactobacillus; Microbial Sensitivity Tests; Micrococcus; Pantoea; Salmonella; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Consumption-based approach for predicting environmental risk in Greece due to the presence of antimicrobials in domestic wastewater.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cefuroxime; Chlorophyta; Daphnia; Drug Utilization; Erythromycin; Fishes; Greece; Humans; Risk Assessment; Rivers; Sewage; Wastewater; Water Quality | 2014 |
Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections.
Topics: Anti-Bacterial Agents; Cefaclor; Ceftriaxone; Cefuroxime; Disk Diffusion Antimicrobial Tests; DNA Gyrase; Drug Resistance, Bacterial; Erythromycin; Humans; Levofloxacin; Penicillins; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Urinary Tract Infections | 2015 |
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atrial Fibrillation; Azithromycin; Cardiotonic Agents; Case-Control Studies; Cefuroxime; Clarithromycin; Death, Sudden; Digoxin; Drug Interactions; Erythromycin; Female; Heart Failure; Humans; Macrolides; Male; Ontario; Risk Factors | 2017 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
Topics: Aeromonas hydrophila; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Dipeptides; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ceftaroline; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.
Topics: Anti-Infective Agents; Borrelia burgdorferi; Borrelia burgdorferi Group; Guidelines as Topic; Humans; Lyme Disease; Microbial Sensitivity Tests; Time Factors | 2009 |
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Phenotype; Sequence Analysis, DNA; Time Factors | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |